{"id":11701,"date":"2026-05-27T17:00:00","date_gmt":"2026-05-27T15:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=19748b2155dc56ad0e09cc9165b51430"},"modified":"2026-05-27T17:00:00","modified_gmt":"2026-05-27T15:00:00","slug":"arima-genomics-announces-presentation-of-new-data-at-asco-2026-supporting-clinical-utility-of-hi-c-sequencing-in-non-small-cell-lung-cancer","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=11701","title":{"rendered":"Arima Genomics Announces Presentation of New Data at ASCO 2026 Supporting Clinical Utility of Hi-C Sequencing in Non-Small Cell Lung Cancer"},"content":{"rendered":"

CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc.<\/a>, a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced that it will present new data at the 2026 American Society of Clinical Oncology<\/a> (ASCO) Annual Meeting, taking place May 29-June 2 in Chicago.<\/p><\/a><\/a>

\nThe findings in the poster presentation demonstrate the value of Arima\u2019s Hi-C sequencing-based approach to fusion and rearrangement detection, available clinically through the Aventa FusionPlus test, for identification of clinically actionable driver alterations in patients with non-small cell lung cancer (NSCLC).<\/p>

\nPoster Presentation Details:<\/b><\/p>

\nP<\/b>oster Board Number:<\/b> 420\nTitle: <\/b>Hi-C Sequencing Can Identify Clinically Actionable Fusions in Non-Small Cell Lung Cancer Missed by Other Sequencing Technologies\nAbstract Number: <\/b>8630\nDate and Time:<\/b> May 31, 2026, 9:00am-12:00pm CDT\nTrack: <\/b>Lung Cancer-Non-Small Cell Metastatic\nPresenter:<\/b> Kevin Levine, M.D., University of Washington\/Fred Hutchinson Cancer Center, Seattle, WA.<\/p>

\nAbout Arima Genomics<\/b><\/p>

\nArima Genomics is a cancer diagnostics company redefining cancer testing by bringing DNA sequence and structure together. Built on leadership in 3D genome science and Hi-C sequencing technology, Arima develops clinical tests that reveal cancer-driving alterations conventional approaches can miss or incompletely characterize. Through its Aventa clinical testing brand, Arima offers testing for solid tumors and lymphoma from its CLIA-certified laboratory in Orlando, Florida. Learn more at www.arimagenomics.com<\/a> and aventatest.com<\/a>, and follow us on LinkedIn<\/a>.<\/p> Contacts<\/b>

\nMedia Contact<\/b>Rachel Ford Hutman\nRachel@fordhutmanmedia.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

CARLSBAD, Calif.–(BUSINESS WIRE)–Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced that it will present new data at the 2026 American Society of Clinic…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-11701","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/11701","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11701"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/11701\/revisions"}],"predecessor-version":[{"id":11702,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/11701\/revisions\/11702"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}